Cargando…

Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives

OBJECTIVE: To evaluate preferences and decision‐making among high‐risk pregnant women offered a choice between Non‐Invasive Prenatal Testing (NIPT), invasive testing or no further testing. METHODS: Nationwide implementation study (TRIDENT) offering NIPT as contingent screening test for women at incr...

Descripción completa

Detalles Bibliográficos
Autores principales: van Schendel, Rachèl V., Page‐Christiaens, G. C. (Lieve), Beulen, Lean, Bilardo, Catia M., de Boer, Marjon A., Coumans, Audrey B. C., Faas, Brigitte H., van Langen, Irene M., Lichtenbelt, Klaske D., van Maarle, Merel C., Macville, Merryn V. E., Oepkes, Dick, Pajkrt, Eva, Henneman, Lidewij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213994/
https://www.ncbi.nlm.nih.gov/pubmed/27739584
http://dx.doi.org/10.1002/pd.4941
_version_ 1782491541441347584
author van Schendel, Rachèl V.
Page‐Christiaens, G. C. (Lieve)
Beulen, Lean
Bilardo, Catia M.
de Boer, Marjon A.
Coumans, Audrey B. C.
Faas, Brigitte H.
van Langen, Irene M.
Lichtenbelt, Klaske D.
van Maarle, Merel C.
Macville, Merryn V. E.
Oepkes, Dick
Pajkrt, Eva
Henneman, Lidewij
author_facet van Schendel, Rachèl V.
Page‐Christiaens, G. C. (Lieve)
Beulen, Lean
Bilardo, Catia M.
de Boer, Marjon A.
Coumans, Audrey B. C.
Faas, Brigitte H.
van Langen, Irene M.
Lichtenbelt, Klaske D.
van Maarle, Merel C.
Macville, Merryn V. E.
Oepkes, Dick
Pajkrt, Eva
Henneman, Lidewij
author_sort van Schendel, Rachèl V.
collection PubMed
description OBJECTIVE: To evaluate preferences and decision‐making among high‐risk pregnant women offered a choice between Non‐Invasive Prenatal Testing (NIPT), invasive testing or no further testing. METHODS: Nationwide implementation study (TRIDENT) offering NIPT as contingent screening test for women at increased risk for fetal aneuploidy based on first‐trimester combined testing (>1:200) or medical history. A questionnaire was completed after counseling assessing knowledge, attitudes and participation following the Multidimensional Measure of Informed Choice. RESULTS: A total of 1091/1253 (87%) women completed the questionnaire. Of these, 1053 (96.5%) underwent NIPT, 37 (3.4%) invasive testing and 1 (0.1%) declined testing. 91.7% preferred NIPT because of test safety. Overall, 77.9% made an informed choice, 89.8% had sufficient knowledge and 90.5% had positive attitudes towards NIPT. Women with intermediate (odds ratio (OR) = 3.51[1.70–7.22], p < 0.001) or high educational level (OR = 4.36[2.22–8.54], p < 0.001) and women with adequate health literacy (OR = 2.60[1.36–4.95], p = 0.004) were more likely to make an informed choice. Informed choice was associated with less decisional conflict and less anxiety (p < 0.001). Intention to terminate the pregnancy for Down syndrome was higher among women undergoing invasive testing (86.5%) compared to those undergoing NIPT (58.4%) (p < 0.001). CONCLUSIONS: The majority of women had sufficient knowledge and made an informed choice. Continuous attention for counseling is required, especially for low‐educated and less health‐literate women. © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.
format Online
Article
Text
id pubmed-5213994
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52139942017-01-18 Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives van Schendel, Rachèl V. Page‐Christiaens, G. C. (Lieve) Beulen, Lean Bilardo, Catia M. de Boer, Marjon A. Coumans, Audrey B. C. Faas, Brigitte H. van Langen, Irene M. Lichtenbelt, Klaske D. van Maarle, Merel C. Macville, Merryn V. E. Oepkes, Dick Pajkrt, Eva Henneman, Lidewij Prenat Diagn Original Articles OBJECTIVE: To evaluate preferences and decision‐making among high‐risk pregnant women offered a choice between Non‐Invasive Prenatal Testing (NIPT), invasive testing or no further testing. METHODS: Nationwide implementation study (TRIDENT) offering NIPT as contingent screening test for women at increased risk for fetal aneuploidy based on first‐trimester combined testing (>1:200) or medical history. A questionnaire was completed after counseling assessing knowledge, attitudes and participation following the Multidimensional Measure of Informed Choice. RESULTS: A total of 1091/1253 (87%) women completed the questionnaire. Of these, 1053 (96.5%) underwent NIPT, 37 (3.4%) invasive testing and 1 (0.1%) declined testing. 91.7% preferred NIPT because of test safety. Overall, 77.9% made an informed choice, 89.8% had sufficient knowledge and 90.5% had positive attitudes towards NIPT. Women with intermediate (odds ratio (OR) = 3.51[1.70–7.22], p < 0.001) or high educational level (OR = 4.36[2.22–8.54], p < 0.001) and women with adequate health literacy (OR = 2.60[1.36–4.95], p = 0.004) were more likely to make an informed choice. Informed choice was associated with less decisional conflict and less anxiety (p < 0.001). Intention to terminate the pregnancy for Down syndrome was higher among women undergoing invasive testing (86.5%) compared to those undergoing NIPT (58.4%) (p < 0.001). CONCLUSIONS: The majority of women had sufficient knowledge and made an informed choice. Continuous attention for counseling is required, especially for low‐educated and less health‐literate women. © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd. John Wiley and Sons Inc. 2016-11-16 2016-12 /pmc/articles/PMC5213994/ /pubmed/27739584 http://dx.doi.org/10.1002/pd.4941 Text en © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
van Schendel, Rachèl V.
Page‐Christiaens, G. C. (Lieve)
Beulen, Lean
Bilardo, Catia M.
de Boer, Marjon A.
Coumans, Audrey B. C.
Faas, Brigitte H.
van Langen, Irene M.
Lichtenbelt, Klaske D.
van Maarle, Merel C.
Macville, Merryn V. E.
Oepkes, Dick
Pajkrt, Eva
Henneman, Lidewij
Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives
title Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives
title_full Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives
title_fullStr Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives
title_full_unstemmed Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives
title_short Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives
title_sort trial by dutch laboratories for evaluation of non‐invasive prenatal testing. part ii—women's perspectives
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213994/
https://www.ncbi.nlm.nih.gov/pubmed/27739584
http://dx.doi.org/10.1002/pd.4941
work_keys_str_mv AT vanschendelrachelv trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT pagechristiaensgclieve trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT beulenlean trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT bilardocatiam trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT deboermarjona trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT coumansaudreybc trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT faasbrigitteh trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT vanlangenirenem trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT lichtenbeltklasked trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT vanmaarlemerelc trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT macvillemerrynve trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT oepkesdick trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT pajkrteva trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT hennemanlidewij trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives
AT trialbydutchlaboratoriesforevaluationofnoninvasiveprenataltestingpartiiwomensperspectives